Diabetes Information [Return To Home Page]

Diabetic Complications - Can Benfotiamine Help Prevent Them?


Diabetic complications contribute too many life threatening diseases globally. The root cause of diabetic complications is elevated glucose levels which contribute to blood vessel damage. Diabetic retinopathy, nephropathy, or neuropathy are caused by damage to small blood vessel in the eyes, nerves and kidneys, etc. The bottom line of this damage is the lowering of the life expectancy of millions of diabetics worldwide.

What Can Be Done About It?

Few therapies are available today that treat diabetic complications. Most healthcare professionals recommend that their patients monitor their blood sugar by taking several blood readings a day to determine the amount of sugar in their blood. Blood sugar readings are generally higher from one to two hours after a meal.

It is suggested by these professionals that keeping blood sugar readings as close to normal as possible will reduce the onset of diabetic complications. Research has shown that there are four, chemical pathways that lead to diabetic complications. Instead of trying to explain these rather difficult chemical pathways, let the reader understand that diabetic complications are mainly caused by excess sugar in the cells, a condition known by the term advanced glycation endproducts (AGE) formation.

The research that was released in 2003 by a team of researchers from the Albert Einstein Collage of Medicine opened the possibilities that it may be possible to actually prevent and/or contain diabetic complications such as retinopathy, neuropathy and heart/circulatory conditions brought about by the presence of advanced glycation endproducts.

What Did This Research Suggest?

The Einstein researchers' work showed that a substance called, "benfotiamine", could reduce the effects of AGE by increasing the amount of an enzyme called transketolase. The research indicated that transketolase was increased by 300% which was enough to make a serious reduction of three of the four chemical pathways that open the door for diabetic complications in terms of vascular damage in diabetics. This vascular damage is directly responsible for the diabetic complications such as neuropathy, retinopathy and heart/circulatory conditions that lead to heart attack and stroke.

Can Benfotaimine Be Considered A Prudent Preventative?

Current research suggests that benfotiamine could possibly reduce the chances of diabetics developing the aforementioned complications. Many healthcare professionals readily recommend patients to add this nutritional supplement to their toolkit in the battle to prevent these insidious conditions that shorten the lives of thousands of diabetics annually.

Where Can I Find More Information About Benfotiamine?

More information about benfotiamine can be found by visiting the web site below and following the links. These links will give the reader a good base to make an informed decision about the use of benfotiamine in the battle against diabetic complications brought about by the presence of advanced glycation endproducts (AGE) which is excess sugar in the blood.

Research:

Hans-Peter Hammes, Xueliang Du, Diane Edelstein, Tetsuya Taguchi, Takeshi Matsumura, Qida Ju, Jihong Lin, Angelika Bierhaus, Peter Nawroth, Dieter Hannak, Michael Neumaier, Regine Bergfeld, Ida Giardino, Michael Brownlee. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nature Medicine 9, 294 - 299 (01 Mar 2003).

Michael Brownlee. Biochemistry and molecular cell biology of diabetic complications Nature 414, 813 - 820 (13 Dec 2001).

Roya Babaei-Jadidi, Nikolaos Karachalias, Naila Ahmed, Sinan Battah, Paul J. Thornalley. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine - Complications. Diabetes. (August 2003).

Zach Malott is CEO of Brentwood Health International, a nutritional supplement company involved in distribution and supplying wholesale, retail and end users.

Mr. Malott is available to discuss the research as it applies to benfotiamine in the treatment and prevention of diabetic complications such as neuropathy and retinopathy.

He can be reached at:

Phone: 505.354.0526

Website: http://www.emuhealthproducts.com


MORE RESOURCES:

The Guardian

Diabetes quadruples birth defects risk, say researchers
BBC News
By James Gallagher Health and science reporter, BBC News The risk of birth defects increases four-fold if the pregnant mother has diabetes, researchers say. The study, published in the journal Diabetologia, analysed data from more than 400000 ...
Diabetes in pregnancy ups birth defects riskTimes of India
Diabetes 'raises birth defect risk'The Press Association
Women with diabetes warned to take precautions when having a babyThe Guardian
Daily Mail
all 209 news articles »


US Drug Watchdog Expands Their Initiative for Diabetics Who Used the Diabetes ...
San Francisco Chronicle (press release)
The US Drug Watchdog says, "We totally underestimated the number of diabetics in the United States, who used the diabetes drug called Actos, and now have bladder cancer. We now believe the number of diabetics, who used the diabetes drug called Actos, ...

and more »


TopNews United States

Diabetes: Celebrating The Silent Killer
Leadership Newspapers
With the worsening incidence of diabetes sweepiing across the world, EZRA IJIOMA examines the different types of diabetes and reasons for its high incidence in Nigeria. In 2003, when he was 21 years old, Ken developed a puzzling, unquenchable thirst.
A Stomach Bug and DiabetesdailyRx
Diabetes is his daily challengeBlacktown Sun
Former office manager, a diabetic, sues Casper company for discriminationCasper Star-Tribune Online
MLB.com -The Cypress Times -TopNews United States
all 11 news articles »


Take steps to detect, reverse pre-diabetes
Wisconsin Rapids Tribune
Pre-diabetes is a condition in which a person's blood sugar is elevated but not high enough to be classified as type 2 diabetes. It's a very important condition to understand because there are so many people who, if they realized they had pre-diabetes, ...
The Diabetic Week in Review -- Week Ending 4 February 2012Examiner.com

all 2 news articles »


Research and Markets: Brazil Diabetes Care Devices Market Outlook to 2017 ...
SunHerald.com
GlobalData's new report, Brazil Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery provides key market data on the Brazil Diabetes Care Devices market. The report provides value (USD million), volume (units) and ...

and more »


Diabetes amputations drop, but disease expands
SouthCoastToday.com
By ANIKA CLARK The Centers for Disease Control and Prevention published good news recently for the nation's diabetic adults. In 2008, substantially fewer of them 40 and older received lower limb amputations than they had 12 years prior.



Diabetes Study Focuses On City Workers
GPB
By Joshua Stewart A new study at UGA will focus on preventing diabetes among government works in Athens-Clarke County, Columbus and Macon by helping them manage their weight. Obesity is a key cause of Type II diabetes. (Photo Courtesy of Jeff Mather ...



PR Web (press release)

Diabetes is One of the Fastest Deadly Growing Diseases around the World
PR Web (press release)
According to the Centers for Disease Control in the USA: Diabetes is an epidemic. 17 million Americans have diabetes with 5.9 million completely unaware that they even have the disease. Diabetes is the 5th leading cause of death in the United States ...



Medical experts meet in S'pore for diabetes workshop
Channel News Asia
SINGAPORE: Leading international experts in type 2 diabetes are in Singapore to address specific challenges and opportunities of bariatric or metabolic surgery for Asian patients and health care systems. The Asia-Pacific Workshop on Metabolic Surgery ...

and more »


The Curse of Amylin's Diabetes Drug Approval
TheStreet.com
... after more than two and a half years, two FDA rejection letters, and at least a dozen amendments to the application, Amylin Pharmaceuticals(AMLN) received FDA approval for Bydureon, a once-weekly formulation of its existing diabetes drug Byetta.


Google News






home | site map
© 2006